結核(TB)治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2989)
◆英語タイトル:Global Tuberculosis (TB) Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2989
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥518,700見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥778,050見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,037,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、結核(TB)治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(イソニアジド、リファンピン(リファディン、リマクタン)、エタンブトール(ミアンブトール)、ピラジナミド)、用途別市場規模(活動性結核、潜在性結核)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・結核(TB)治療の市場動向
・企業の競争状況、市場シェア
・結核(TB)治療の種類別市場規模(イソニアジド、リファンピン(リファディン、リマクタン)、エタンブトール(ミアンブトール)、ピラジナミド)
・結核(TB)治療の用途別市場規模(活動性結核、潜在性結核)
・結核(TB)治療の北米市場規模2016-2027(アメリカ、カナダ)
・結核(TB)治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・結核(TB)治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・結核(TB)治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・結核(TB)治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Johnson & Johnson、Otsuka Pharmaceutical Co., Ltd、Macleods Pharmaceutical Ltd、Dong-A ST Co., Ltd、Lupin Ltd、Janssen Products, LP、Mylan、Sanofi)
・結論
【レポートの概要】

If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it’s a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include:
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide

Market Analysis and Insights: Global Tuberculosis (TB) Treatment Market
The global Tuberculosis (TB) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tuberculosis (TB) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tuberculosis (TB) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tuberculosis (TB) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tuberculosis (TB) Treatment market.

Global Tuberculosis (TB) Treatment Scope and Market Size
Tuberculosis (TB) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis (TB) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide

Segment by Application
Active TB
Latent TB

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd
Macleods Pharmaceutical Ltd
Dong-A ST Co., Ltd
Lupin Ltd
Janssen Products, LP
Mylan
Sanofi

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Isoniazid
1.2.3 Rifampin (Rifadin, Rimactane)
1.2.4 Ethambutol (Myambutol)
1.2.5 Pyrazinamide
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Active TB
1.3.3 Latent TB
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tuberculosis (TB) Treatment Market Perspective (2016-2027)
2.2 Tuberculosis (TB) Treatment Growth Trends by Regions
2.2.1 Tuberculosis (TB) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tuberculosis (TB) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Tuberculosis (TB) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Tuberculosis (TB) Treatment Industry Dynamic
2.3.1 Tuberculosis (TB) Treatment Market Trends
2.3.2 Tuberculosis (TB) Treatment Market Drivers
2.3.3 Tuberculosis (TB) Treatment Market Challenges
2.3.4 Tuberculosis (TB) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis (TB) Treatment Players by Revenue
3.1.1 Global Top Tuberculosis (TB) Treatment Players by Revenue (2016-2021)
3.1.2 Global Tuberculosis (TB) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Tuberculosis (TB) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis (TB) Treatment Revenue
3.4 Global Tuberculosis (TB) Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis (TB) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Treatment Revenue in 2020
3.5 Tuberculosis (TB) Treatment Key Players Head office and Area Served
3.6 Key Players Tuberculosis (TB) Treatment Product Solution and Service
3.7 Date of Enter into Tuberculosis (TB) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tuberculosis (TB) Treatment Breakdown Data by Type
4.1 Global Tuberculosis (TB) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2022-2027)

5 Tuberculosis (TB) Treatment Breakdown Data by Application
5.1 Global Tuberculosis (TB) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tuberculosis (TB) Treatment Market Size (2016-2027)
6.2 North America Tuberculosis (TB) Treatment Market Size by Type
6.2.1 North America Tuberculosis (TB) Treatment Market Size by Type (2016-2021)
6.2.2 North America Tuberculosis (TB) Treatment Market Size by Type (2022-2027)
6.2.3 North America Tuberculosis (TB) Treatment Market Size by Type (2016-2027)
6.3 North America Tuberculosis (TB) Treatment Market Size by Application
6.3.1 North America Tuberculosis (TB) Treatment Market Size by Application (2016-2021)
6.3.2 North America Tuberculosis (TB) Treatment Market Size by Application (2022-2027)
6.3.3 North America Tuberculosis (TB) Treatment Market Size by Application (2016-2027)
6.4 North America Tuberculosis (TB) Treatment Market Size by Country
6.4.1 North America Tuberculosis (TB) Treatment Market Size by Country (2016-2021)
6.4.2 North America Tuberculosis (TB) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Tuberculosis (TB) Treatment Market Size (2016-2027)
7.2 Europe Tuberculosis (TB) Treatment Market Size by Type
7.2.1 Europe Tuberculosis (TB) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Tuberculosis (TB) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Tuberculosis (TB) Treatment Market Size by Type (2016-2027)
7.3 Europe Tuberculosis (TB) Treatment Market Size by Application
7.3.1 Europe Tuberculosis (TB) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Tuberculosis (TB) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Tuberculosis (TB) Treatment Market Size by Application (2016-2027)
7.4 Europe Tuberculosis (TB) Treatment Market Size by Country
7.4.1 Europe Tuberculosis (TB) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Tuberculosis (TB) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Type
8.2.1 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Application
8.3.1 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region
8.4.1 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tuberculosis (TB) Treatment Market Size (2016-2027)
9.2 Latin America Tuberculosis (TB) Treatment Market Size by Type
9.2.1 Latin America Tuberculosis (TB) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Tuberculosis (TB) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Tuberculosis (TB) Treatment Market Size by Type (2016-2027)
9.3 Latin America Tuberculosis (TB) Treatment Market Size by Application
9.3.1 Latin America Tuberculosis (TB) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Tuberculosis (TB) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Tuberculosis (TB) Treatment Market Size by Application (2016-2027)
9.4 Latin America Tuberculosis (TB) Treatment Market Size by Country
9.4.1 Latin America Tuberculosis (TB) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Tuberculosis (TB) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type
10.2.1 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application
10.3.1 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country
10.4.1 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Otsuka Pharmaceutical Co., Ltd
11.2.1 Otsuka Pharmaceutical Co., Ltd Company Details
11.2.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.2.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Introduction
11.2.4 Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.2.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.3 Macleods Pharmaceutical Ltd
11.3.1 Macleods Pharmaceutical Ltd Company Details
11.3.2 Macleods Pharmaceutical Ltd Business Overview
11.3.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Introduction
11.3.4 Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.3.5 Macleods Pharmaceutical Ltd Recent Development
11.4 Dong-A ST Co., Ltd
11.4.1 Dong-A ST Co., Ltd Company Details
11.4.2 Dong-A ST Co., Ltd Business Overview
11.4.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Introduction
11.4.4 Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.4.5 Dong-A ST Co., Ltd Recent Development
11.5 Lupin Ltd
11.5.1 Lupin Ltd Company Details
11.5.2 Lupin Ltd Business Overview
11.5.3 Lupin Ltd Tuberculosis (TB) Treatment Introduction
11.5.4 Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.5.5 Lupin Ltd Recent Development
11.6 Janssen Products, LP
11.6.1 Janssen Products, LP Company Details
11.6.2 Janssen Products, LP Business Overview
11.6.3 Janssen Products, LP Tuberculosis (TB) Treatment Introduction
11.6.4 Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.6.5 Janssen Products, LP Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Tuberculosis (TB) Treatment Introduction
11.7.4 Mylan Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Tuberculosis (TB) Treatment Introduction
11.8.4 Sanofi Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.8.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 結核(TB)治療の世界市場規模・現状・予測2021年-2027年(Global Tuberculosis (TB) Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。